Advanced Search:
Equity Index Forex Crypto Commodity

NVS - Novartis AG

$93.52  -0.82 (-0.87%)

Updated: 03:18 May 5, 2024 EST

Next Hour's AI Forecast

99.73%

Avg. Accuracy (AI)

$99.35

Next Session's AI Forecast

98.47%

Avg. Accuracy (AI)

$95.92

Next Week's AI Forecast

100%

Trend's Accuracy (AI)

$95.07

Novartis AG's Position Within the Drug Manufacturers—General Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

NOVARTIS AG - HISTORICAL DATA 6M

  • Last price

    $ 93.52

  • Daily change

    $ -0.82

  • Previous Close

    $ 94.34

  • Last Updated

    03:18 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.08 0.12 -0.12 0 -0.03

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.23 0.78 0.83 0.81 0.83

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 32.49% 79.51% 45.54%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
98.4 1.14% 97.29 1.49% 95.86 -3.32% 99.15

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
0.61 54.13 3.26 37.89

Novartis AG Technical Analysis News

Novartis AG

Lichtstrasse 35
Basel 4056
Switzerland
41 61 324 1111
https://www.novartis.com

Sectors: Healthcare
Industry: Drug Manufacturers—General
F. Time Employees: 76057
Description

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Corporate Governance

Novartis AG’s ISS Governance QualityScore as of May 1, 2024 is 1. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 1; Compensation: 3.

NOVARTIS AG'S HOLDERS RANK

List of holders with stock participation in Novartis AG.

Holder Rank Holder Shares Date Reported % Out Value